Learn More
Medchemexpress LLC Camizestrant | 2222844-89-3 | 99.3% | 476.51 | 50 MG

Supplier: Medchemexpress LLC HY13625550MG
Camizestrant is a potent and orally active estrogen receptor (ER) antagonist. It is used for the study of ER+ HER2-advanced breast cancer. It exhibits anti-tumour efficacy in a dose-dependent manner in human parental MCF7 mice xenograft and decreases tumor growth in mice, with almost complete tumor growth inhibition at doses >10 mg/kg.
- Potent and orally active estrogen receptor (ER) antagonist
- Used for the study of ER+ HER2-advanced breast cancer
- Exhibits anti-tumour efficacy in a dose-dependent manner
- Decreases tumor growth in mice with significant inhibition at doses >10 mg/kg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.